Granulomatous disease in CVID: retrospective analysis of clinical characteristics and treatment efficacy in a cohort of 59 patients.
about
International Consensus Document (ICON): Common Variable Immunodeficiency DisordersMechanism-Based Strategies for the Management of Autoimmunity and Immune Dysregulation in Primary ImmunodeficienciesGastrointestinal Disorders Associated with Common Variable Immune Deficiency (CVID) and Chronic Granulomatous Disease (CGD)Progression of Common Variable Immunodeficiency Interstitial Lung Disease Accompanies Distinct Pulmonary and Laboratory Findings.Tertiary lymphoid neogenesis is a component of pulmonary lymphoid hyperplasia in patients with common variable immunodeficiencyLow Circulating Natural Killer Cell Counts are Associated With Severe Disease in Patients With Common Variable Immunodeficiency.Expansion of inflammatory innate lymphoid cells in patients with common variable immune deficiencyImmunopathogenesis of granulomas in chronic autoinflammatory diseases.Idiopathic non cirrhotic portal hypertension and spleno-portal axis abnormalities in patients with severe primary antibody deficiencies.A review on guidelines for management and treatment of common variable immunodeficiency.Chloroquine analogues in drug discovery: new directions of uses, mechanisms of actions and toxic manifestations from malaria to multifarious diseases.Cutaneous granulomas in the setting of primary immunodeficiency: a report of four cases and review of the literature.Autoimmune and Lymphoproliferative Complications of Common Variable Immunodeficiency.Lung Disease in Primary Antibody Deficiencies.An Update on the Use of Immunomodulators in Primary Immunodeficiencies.The Lung in Dysregulated States of Humoral Immunity.Common Variable Immunodeficiency and Liver Involvement.Dysregulation of Innate Lymphoid Cells in Common Variable Immunodeficiency.Autoimmunity/inflammation in a monogenic primary immunodeficiency cohortInfliximab for treatment of granulomatous disease in patients with common variable immunodeficiency.Applying T-cell receptor excision circles and immunoglobulin κ-deleting recombination excision circles to patients with primary immunodeficiency diseases.Ill-defined germinal centers and severely reduced plasma cells are histological hallmarks of lymphadenopathy in patients with common variable immunodeficiency.Granulomatous-Lymphocytic Interstitial Lung Disease in 22q11.2 Deletion Syndrome: a Case Report and Literature Review.HLA-A29 negative Birdshot-like chorioretinopathy associated with common variable immunodeficiency.
P2860
Q26777304-5A2C3E3E-89EB-4F3F-BF7F-8753CE358B89Q28066193-049931E9-B585-4A95-A183-F55842A64FD9Q28072810-2A25D035-3F1B-498F-9E6D-993BABD1B4CAQ33425862-E34325DF-3A24-4F57-BA11-1557DF9F45A9Q33942410-8288119F-5DCF-4D47-A077-623F49DF675AQ36869908-52B4B322-72AB-48CC-9903-5BE95DFC30F9Q36900160-E1007E71-3E96-4A77-B05B-02DEBBFD66F4Q37538526-5D911A0A-CF19-4396-B1C0-062A7286DD89Q37706062-EBE89DC4-1F10-4706-8A62-1EEA5C6A3033Q38111423-0DFF19AE-3CE9-41CB-92CD-BC3661549A11Q38360827-25DE20B1-D862-4BE1-A2D6-DA57D1FA4F57Q38379052-56F901E0-8B95-4FE0-A524-249EC7ADF11CQ38726509-E2E8E060-88EF-413B-AF40-A8D2C4EE54A3Q39005508-299D6079-5B3E-4FF8-AB46-64A32EF5085DQ39016299-14F967C6-DFEE-444B-A7CE-35E6CD6C8F65Q40045962-683E05C3-62A4-409C-994E-866217FBF77FQ40102527-77553A7E-6F73-461A-A2E2-6C1628B99BE5Q41990559-DA9D3909-4ED3-4E66-90F8-160A0DF3EE84Q41990601-695B2E05-B16E-4CAA-AEA2-27A587902F76Q43793814-9D5C661A-39FA-4ED7-937C-454FC14F8AAAQ50787758-39188475-5A16-467C-8B6B-50924793D43CQ50850618-35985493-8669-42FA-893C-DC7C43C74717Q52730992-627A89C8-E824-4550-8274-7AB3D26D1ED5Q54986621-BBADCD22-BBC5-4797-B3D6-9FD0F319B8FE
P2860
Granulomatous disease in CVID: retrospective analysis of clinical characteristics and treatment efficacy in a cohort of 59 patients.
description
2012 nî lūn-bûn
@nan
2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Granulomatous disease in CVID: ...... cy in a cohort of 59 patients.
@ast
Granulomatous disease in CVID: ...... cy in a cohort of 59 patients.
@en
Granulomatous disease in CVID: ...... cy in a cohort of 59 patients.
@nl
type
label
Granulomatous disease in CVID: ...... cy in a cohort of 59 patients.
@ast
Granulomatous disease in CVID: ...... cy in a cohort of 59 patients.
@en
Granulomatous disease in CVID: ...... cy in a cohort of 59 patients.
@nl
prefLabel
Granulomatous disease in CVID: ...... cy in a cohort of 59 patients.
@ast
Granulomatous disease in CVID: ...... cy in a cohort of 59 patients.
@en
Granulomatous disease in CVID: ...... cy in a cohort of 59 patients.
@nl
P2093
P2860
P50
P1476
Granulomatous disease in CVID: ...... cy in a cohort of 59 patients.
@en
P2093
Alice Berezne
Claire Fieschi
DEFI study group
Eric Oksenhendler
Jean-François Viallard
Jean-Nicolas Boursiquot
Laurence Gérard
Laurent Têtu
Lionel Galicier
Marion Malphettes
P2860
P2888
P356
10.1007/S10875-012-9778-9
P577
2012-09-18T00:00:00Z
P6179
1019388351